Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Inspire Medical Systems Inc (NYSE: INSP) closed the day trading at $87.91 down -32.35% from the previous closing price of $129.95. In other words, the price has decreased by -$32.35 from its previous closing price. On the day, 10.96 million shares were traded. INSP stock price reached its highest trading level at $89.51 during the session, while it also had its lowest trading level at $73.92.
Ratios:
For a better understanding of INSP, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.62 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.50. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 6.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
JP Morgan Downgraded its Overweight to Neutral on August 05, 2025, while the target price for the stock was maintained at $110.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 19 ’25 when Rondoni John sold 1,734 shares for $149.38 per share. The transaction valued at 259,025 led to the insider holds 13,766 shares of the business.
JOHN RONDONI bought 1,734 shares of INSP for $259,025 on May 19 ’25. On May 02 ’25, another insider, mcCormick Shawn, who serves as the Director of the company, sold 360 shares for $160.00 each. As a result, the insider received 57,600 and left with 24,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 2599876864 and an Enterprise Value of 2332042240. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 50.93, and their Forward P/E ratio for the next fiscal year is 53.44. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.01 while its Price-to-Book (P/B) ratio in mrq is 3.84. Its current Enterprise Value per Revenue stands at 2.708 whereas that against EBITDA is 44.686.
Stock Price History:
The Beta on a monthly basis for INSP is 1.16, which has changed by -0.5333369 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $225.00, while it has fallen to a 52-week low of $123.25. The 50-Day Moving Average of the stock is -32.89%, while the 200-Day Moving Average is calculated to be -47.01%.
Shares Statistics:
Over the past 3-months, INSP traded about 592.63K shares per day on average, while over the past 10 days, INSP traded about 1663890 shares per day. A total of 29.57M shares are outstanding, with a floating share count of 27.84M. Insiders hold about 5.61% of the company’s shares, while institutions hold 111.55% stake in the company. Shares short for INSP as of 1752537600 were 3290632 with a Short Ratio of 5.55, compared to 1749772800 on 3398569. Therefore, it implies a Short% of Shares Outstanding of 3290632 and a Short% of Float of 15.0.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
